T
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
T. Burrow's research focuses on the diagnosis and management of rare genetic metabolic and neurological disorders, particularly in pediatric populations. Burrow has investigated glycogen storage diseases, including type IV and adult polyglucosan body disease, and Pompe disease, contributing to clinical trials and practice resources. Their work also encompasses Gaucher disease in children and other rare conditions such as Wolman disease and δ-aminolevulinic acid dehydratase deficient porphyria. Additionally, Burrow has explored mitochondrial ultrastructural defects and the genetic basis of neurodevelopmental disorders, including variants in the BSN gene.
With a career marked by extensive publication, Burrow has authored 199 works, accumulating 1,277 citations and an h-index of 21. They are recognized as a highly cited researcher. Burrow collaborates with several colleagues at the University of Arkansas for Medical Sciences, including Thomas Andrew Burrow, Carissa Rodriquez, Hannah Barkley, and Mark Roberts, with whom they have co-authored multiple publications. Burrow maintains an active lab website to disseminate their research findings.
Metrics
- h-index: 21
- Publications: 197
- Citations: 1,248
Selected Publications
-
Diagnostic Odyssey of Atypical Long‐Chain 3‐Hydroxyacyl‐ <scp>CoA</scp> Dehydrogenase Deficiency ( <scp>LCHADD</scp> ) Explained by Three Allelic Products From Two Pathogenic Variants (2026)
-
Central nervous system-symptomatic hyperammonemia following recombinant crisantaspase Pseudomonas fluorescens (2026)
-
Longitudinal Observation of Children with Achondroplasia: Findings from a Global Natural History Study (ACHieve) (2026)
-
Variants in BSN, encoding the presynaptic protein Bassoon, result in a distinct neurodevelopmental disorder with a broad phenotypic range (2025)
-
Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria (2025)
-
Variants in <i>BSN</i> , encoding the presynaptic protein Bassoon, result in a novel neurodevelopmental disorder with a broad phenotypic range (2025)
-
Neurodevelopmental delay, musculoskeletal disorders and dysmorphia associated with a novel pathogenic interstitial deletion of chromosome 10q21.1q21.3 (2025)
-
Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria (2024)
-
04145 Profound hypotonia in a newborn with Biallelic δ-Aminolevulinic Acid Dehydratase (ALAD) mutations (2024)
-
Design of a Phase 3 study of AAV-mediated gene transfer of ornithine transcarbamylase (OTC) in patients with late-onset OTC deficiency (2024)
-
DESIGN OF A PHASE 3 STUDY OF AAV-MEDIATED GENE TRANSFER OF ORNITHINE TRANSCARBAMYLASE (OTC) IN PATIENTS WITH LATE-ONSET OTC DEFICIENCY (2023)
-
Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource (2023)
-
Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly (2022)
-
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? (2022)
-
Mitochondrial Ultrastructural Defects in NDUFS3-Related Disorder (2021)
Grants & Funding
Collaboration Network
Top Collaborators
Priya S. Kishnani
5 shared publications
- The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
- Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
- Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly
- COVID-19 patient impact: A survey of the Gaucher community involving patients, caregivers and family members based in the US to determine impact of the pandemic
- O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV*
Raphael Schiffmann
3 shared publications
- Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
- COVID-19 patient impact: A survey of the Gaucher community involving patients, caregivers and family members based in the US to determine impact of the pandemic
- O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV*
Nicola Longo
University of Utah (US)
3 shared publications
- The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
- DESIGN OF A PHASE 3 STUDY OF AAV-MEDIATED GENE TRANSFER OF ORNITHINE TRANSCARBAMYLASE (OTC) IN PATIENTS WITH LATE-ONSET OTC DEFICIENCY
- Design of a Phase 3 study of AAV-mediated gene transfer of ornithine transcarbamylase (OTC) in patients with late-onset OTC deficiency
Surekha Pendyal
3 shared publications
- Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
- Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly
- O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV*
Hannah Barkley
University of Arkansas for Medical Sciences
3 shared publications
In database
- Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
- 04145 Profound hypotonia in a newborn with Biallelic δ-Aminolevulinic Acid Dehydratase (ALAD) mutations
- Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
Carissa Rodriquez
Arkansas Children's Hospital
3 shared publications
In database
- Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
- 04145 Profound hypotonia in a newborn with Biallelic δ-Aminolevulinic Acid Dehydratase (ALAD) mutations
- Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
Karl E. Anderson
The University of Texas Medical Branch at Galveston (US)
3 shared publications
- Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
- 04145 Profound hypotonia in a newborn with Biallelic δ-Aminolevulinic Acid Dehydratase (ALAD) mutations
- Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria
Özlem Göker-Alpan
Lysosomal and Rare Disorders Research and Treatment Center (US)
2 shared publications
- The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
- COVID-19 patient impact: A survey of the Gaucher community involving patients, caregivers and family members based in the US to determine impact of the pandemic
Neal J. Weinreb
University of Miami (US)
2 shared publications
- The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
- COVID-19 patient impact: A survey of the Gaucher community involving patients, caregivers and family members based in the US to determine impact of the pandemic
Claudia Soler‐Alfonso
2 shared publications
- Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
- O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV*
Akihiro Asai
2 shared publications
- Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
- O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV*
Ariana L. Smith
2 shared publications
- Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
- O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV*
Deeksha Bali
2 shared publications
- Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
- O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV*
Peter B. Kang
2 shared publications
- Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
- O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV*
Andrew P. Landstrom
2 shared publications
- Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
- O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV*
Similar Researchers
Based on overlapping research topics
Aravindhan Veerapandiyan
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Neurological disorders and treatments
Disease Mechanisms Research
Thomas Andrew Burrow
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Neurological disorders and treatments
Disease Mechanisms Research
Michelle A. Johnson
University of Arkansas at Fayetteville
Metabolism and Genetic Disorders
Neurological disorders and treatments
Disease Mechanisms Research
Aixa Gonzalez Garcia
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Neurological disorders and treatments
Disease Mechanisms Research
Harshawardhan Pande
University of Arkansas – Fort Smith
Metabolism and Genetic Disorders
Neurological disorders and treatments
Disease Mechanisms Research
Emily Montoya
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Child and Adolescent Health
Health Sciences Research and Education